Patents/Assignees

MEDIVIR AB

6 patents in portfolio

US12479870utility2025
Base-modified Cytidine Nucleotides for Leukemia Therapy
0 cites
US12378209utility2025
Protease Inhibitors
0 cites
US12303521utility2025
Methods for Treating Liver Cancers Using an Orally Administered Dioxolane Nucleotide in Combination with an Anti-pd1 or Anti-pdl1 Monoclonal Antibody
0 cites
US12221459utility2025
Cancer Treatment with (2,2-bishydroxymethyl) Methylenecyclopropane Nucleotides
0 cites
US11951147utility2024
SMAC Mimetic
0 cites
US11607399utility2023
Pharmaceutical Formulation for Histone Deacetylase Inhibitors
0 cites